Open Label Extension of a Clinical Trial of Intravitreal Triamcinolone for Diabetic Macular Oedema-TDMX Study

Clinical trial NCT00148330 · COMPLETED

Trial details

NCT number: NCT00148330
Sponsor: University of Sydney
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diabetic Macular Oedema

Start date: 2005-05-01
Primary completion: 2008-07-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.